Injectable cell therapy could repair complex bone fractures, U of Michigan researchers find

University of Michigan have developed technology to reprogram adult cells from bone marrow so that they can be injected directly into a wound and grow into bone, according to the university.
The marrow-derived cells are known as progenitor cells, a type of adult stem cell that maintains the ability to differentiate into several different cell types, according to a university article.

Jan Stegemann, a University of Michigan professor of biomedical engineering led the research. Testing in mice has shown that a cell-based therapy created at Michigan can drastically accelerate the bone regeneration process after injury, according to the article.

His research team's latest work, titled, “Injectable osteogenic microtissues containing mesenchymal stromal cells conformally fill and repair critical-size defects,” is published in the journal Biomaterials.

Read a Q&A with Stegemann about the research HERE.